The visual system in Parkinson's disease.
Bodis-Wollner
I
I
Department of Neurology, Mount Sinai School of Medicine, New York, New York 10029.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D015350:Contrast Sensitivity; D004298:Dopamine / Q000172:deficiency; D004569:Electroencephalography; D005074:Evoked Potentials, Visual; D000882:Haplorhini; D006801:Humans; D010300:Parkinson Disease / Q000150:complications / Q000503:physiopathology*; D012160:Retina / Q000378:metabolism / Q000503:physiopathology; D014786:Vision Disorders / Q000209:etiology / Q000503:physiopathology*
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine